Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Haag

Showing results (51-60 of 76) with videos related to

Pageof 8
Sort By:
Annals of Surgical Oncology|July 5, 2024
Prognostic Relevance of the Proximal Resection Margin Distance in Distal Gastrectomy for Gastric AdenocarcinomaIngmar F Rompen, Isabel Schütte, Nerma Crnovrsanin, et al.
Annals of Surgical Oncology|July 10, 2024
ASO Author Reflections: The Prognostic Relevance of the Proximal Resection Margin Distance is Dependent upon the Histological Subtype of Gastric AdenocarcinomaIngmar F Rompen, Isabel Schütte, Nerma Crnovrsanin, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 8, 2018
Prognostic differences in 8th edition TNM staging of esophagogastric adenocarcinoma after neoadjuvant treatmentLeila Sisic, Susanne Blank, Henrik Nienhüser, et al.
Cancers|April 30, 2021
Efficacy and Safety of Checkpoint Inhibitor Treatment in Patients with Advanced Renal or Urothelial Cell Carcinoma and Concomitant Chronic Kidney Disease: A Retrospective Cohort StudyFlorian Seydel, Susanne Delecluse, Martin Zeier, et al.
BMC Cancer|March 24, 2012
A phase II study for metabolic in vivo response monitoring with sequential 18FDG-PET-CT during treatment with the EGFR-monoclonal-antibody cetuximab in metastatic colorectal cancer: the Heidelberg REMOTUX trialAnne Katrin Berger, Carl von Gall, Ulrich Abel, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|April 5, 2025
The role of placental growth factor as a biomarker in patients with resectable gastric cancerIngmar F Rompen, Daniel Nerz, Nerma Crnovrsanin, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|July 8, 2017
Surgical strategies in true adenocarcinoma of the esophagogastric junction (AEG II): thoracoabdominal or abdominal approach?Susanne Blank, Thomas Schmidt, Patrick Heger, et al.
Annals of Surgical Oncology|March 25, 2025
β-Blockers Influence Oncological Outcomes in Gastric Cancer Patients Treated with Neoadjuvant Chemotherapy Based on the Pathological Subtype: A Retrospective Cohort StudyNerma Crnovrsanin, Sarah Zumsande, Ingmar Florin Rompen, et al.
Annals of Surgical Oncology|May 3, 2025
ASO Visual Abstract: Beta-Blockers Influence Oncological Outcomes in Patients with Gastric Cancer Treated with Neoadjuvant Chemotherapy on the Basis of the Pathological Subtype-A Retrospective Cohort StudyNerma Crnovrsanin, Sarah Zumsande, Ingmar F Rompen, et al.
Annals of Surgical Oncology|April 24, 2025
ASO Author Reflections: The Role of Beta-Blockers in Gastric Cancer-A Pathway to Personalized Therapy?Nerma Crnovrsanin, Sarah Zumsande, Ingmar F Rompen, et al.
Pageof 8

Showing results (51-60 of 76) with videos related to

Sort By:
Pageof 8
Annals of Surgical Oncology|July 5, 2024
Prognostic Relevance of the Proximal Resection Margin Distance in Distal Gastrectomy for Gastric AdenocarcinomaIngmar F Rompen, Isabel Schütte, Nerma Crnovrsanin, et al.
Annals of Surgical Oncology|July 10, 2024
ASO Author Reflections: The Prognostic Relevance of the Proximal Resection Margin Distance is Dependent upon the Histological Subtype of Gastric AdenocarcinomaIngmar F Rompen, Isabel Schütte, Nerma Crnovrsanin, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 8, 2018
Prognostic differences in 8th edition TNM staging of esophagogastric adenocarcinoma after neoadjuvant treatmentLeila Sisic, Susanne Blank, Henrik Nienhüser, et al.
Cancers|April 30, 2021
Efficacy and Safety of Checkpoint Inhibitor Treatment in Patients with Advanced Renal or Urothelial Cell Carcinoma and Concomitant Chronic Kidney Disease: A Retrospective Cohort StudyFlorian Seydel, Susanne Delecluse, Martin Zeier, et al.
BMC Cancer|March 24, 2012
A phase II study for metabolic in vivo response monitoring with sequential 18FDG-PET-CT during treatment with the EGFR-monoclonal-antibody cetuximab in metastatic colorectal cancer: the Heidelberg REMOTUX trialAnne Katrin Berger, Carl von Gall, Ulrich Abel, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|April 5, 2025
The role of placental growth factor as a biomarker in patients with resectable gastric cancerIngmar F Rompen, Daniel Nerz, Nerma Crnovrsanin, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|July 8, 2017
Surgical strategies in true adenocarcinoma of the esophagogastric junction (AEG II): thoracoabdominal or abdominal approach?Susanne Blank, Thomas Schmidt, Patrick Heger, et al.
Annals of Surgical Oncology|March 25, 2025
β-Blockers Influence Oncological Outcomes in Gastric Cancer Patients Treated with Neoadjuvant Chemotherapy Based on the Pathological Subtype: A Retrospective Cohort StudyNerma Crnovrsanin, Sarah Zumsande, Ingmar Florin Rompen, et al.
Annals of Surgical Oncology|May 3, 2025
ASO Visual Abstract: Beta-Blockers Influence Oncological Outcomes in Patients with Gastric Cancer Treated with Neoadjuvant Chemotherapy on the Basis of the Pathological Subtype-A Retrospective Cohort StudyNerma Crnovrsanin, Sarah Zumsande, Ingmar F Rompen, et al.
Annals of Surgical Oncology|April 24, 2025
ASO Author Reflections: The Role of Beta-Blockers in Gastric Cancer-A Pathway to Personalized Therapy?Nerma Crnovrsanin, Sarah Zumsande, Ingmar F Rompen, et al.
Pageof 8